• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    73 Biggest Movers From Yesterday

    5/17/22 4:49:25 AM ET
    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACLX alert in real time by email

    Gainers

    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
    • NewAge, Inc. (NASDAQ:NBEV) gained 65.8% to settle at $0.4245.
    • Data Storage Corporation (NASDAQ:DTST) shares climbed 50% to close at $3.45 on Monday after the company reported better-than-expected Q1 financial results.
    • Trevena, Inc. (NASDAQ:TRVN) rose 49.2% to settle at $0.3028. Trevena recently posted a Q1 loss of $0.10 per share.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) jumped 39% to close at $0.2978. Corbus Pharmaceuticals recently posted a Q1 loss of $0.08 per share.
    • Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.2% to settle at $2.21. Xeris Pharmaceuticals recently posted a Q1 loss of $0.25 per share.
    • Aspira Women's Health Inc. (NASDAQ:AWH) jumped 28.6% to close at $0.58. Aspira Womens Health recently posted a Q1 loss of $0.08 per share.
    • Indonesia Energy Corporation Limited (NYSE:INDO) gained 27.1% to close at $17.54.
    • High Tide Inc. (NASDAQ:HITI) surged 26.7% to settle at $2.28.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) rose 26.5% to close at $2.15. Pulse Biosciences recently posted a Q1 loss of $0.58 per share.
    • Arcadia Biosciences, Inc. (NASDAQ:RKDA) jumped 24.8% to settle at $1.26. Arcadia Biosciences recently reported better-than-expected Q1 EPS and sales results.
    • Crexendo, Inc. (NASDAQ:CXDO) gained 24.6% to close at $2.99. Crexendo recently posted Q1 EPS of $0.02.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) rose 24.6% to settle at $3.50.
    • Carver Bancorp, Inc. (NASDAQ:CARV) gained 24.2% to close at $10.06.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) climbed 24.6% to close at $3.50. ORIC Pharmaceuticals recently posted a Q1 loss of $0.59 per share.
    • Griffon Corporation (NYSE:GFF) gained 23.9% to close at $30.13. Griffon announced review of strategic alternatives.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) rose 23.9% to close at $2.85. Vigil Neuroscience posted a Q1 loss of $0.58 per share.
    • Clever Leaves Holdings Inc. (NASDAQ:CLVR) gained 22.6% to settle at $1.30. Clever Leaves recently reported its financial and operating results for the first quarter ended March 31, 2022.
    • Creative Realities, Inc. (NASDAQ:CREX) surged 22.3% to close at $0.85. Creative Realities posted Q1 sales of $10.80 million.
    • Benson Hill, Inc. (NYSE:BHIL) climbed 21.6% to close at $3.66 following strong quarterly results.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) rose 21.5% to close at $1.81.
    • RiceBran Technologies (NASDAQ:RIBT) gained 21.2% to close at $0.63.
    • Sundial Growers Inc. (NASDAQ:SNDL) climbed 21.1% to close at $0.4650. Delta 9 Cannabis released financial and operating results for the three-month period ending March 31, 2022, reporting net revenue of $12.5 million.
    • Applied Blockchain, Inc. (NASDAQ:APLD) gained 21.2% to close at $2.18. Applied Blockchain posted a Q3 loss of $0.12 per share.
    • Ontrak, Inc. (NASDAQ:OTRK) rose 21% to settle at $1.67. Ontrak recently issued FY22 sales guidance below analyst estimates.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) gained 20.7% to close at $0.4646. Adamis Pharmaceuticals posted Q1 sales of $1.20 million.
    • Eargo, Inc. (NASDAQ:EAR) jumped 20.3% to close at $1.54. Eargo received Nasdaq notice of non-compliance related to filing of the company’s 10-Q, 10-K.
    • Eve Holding, Inc. (NYSE:EVEX) rose 20.2% to settle at $7.63.
    • Urban One, Inc. (NASDAQ:UONE) gained 19.8% to close at $11.26.
    • Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) rose 18.9% to close at $24.41. Zentalis Pharmaceuticals priced 10,330,000 share common stock offering at $19.38 per share.
    • Tidewater Inc. (NYSE:TDW) climbed 17.3% to close at $24.96.
    • ManTech International Corporation (NASDAQ:MANT) climbed 15% to close at $94.29. Carlyle announced plans to acquire ManTech in all-cash transaction valued at $4.2 billion.
    • iQIYI, Inc. (NASDAQ:IQ) shares rose 14.8% to close at $3.41. JP Morgan upgraded iQIYI from Underweight to Overweight and raised the price target from $2 to $8.
    • Rattler Midstream LP (NASDAQ:RTLR) rose 14.2% to close at $14.67 after Diamondback Energy announced it would acquire publicly held shares of Rattler Midstream for 0.113 shares of Diamondback Energy.
    • Greenland Technologies Holding Corporation (NASDAQ:GTEC) rose 14.1% to settle at $3.15. Greenland Technologies reported a first-quarter FY22 revenue increase of 19% to $29.3 million, beating the consensus of $24.36 million.
    • Spirit Airlines, Inc. (NYSE:SAVE) shares rose 13.5% to close at $19.27 after JetBlue appealed directly to Spirit shareholders for consideration of JetBlue's acquisition offer of the company at $30 per share.
    • Teekay Tankers Ltd. (NYSE:TNK) jumped 13.1% to close at $18.08. The company recently released quarterly results.
    • Clear Secure, Inc. (NYSE:YOU) gained 12.7% to settle at $31.85 after the company announced better-than-expected financial expectations for the upcoming quarter and announced a $100M buyback plan.
    • Nephros, Inc. (NASDAQ:NEPH) climbed 10.7% to close at $2.27. Nephros recently reported worse-than-expected Q1 EPS and sales results and withdrew its FY22 revenue guidance.
    • CorMedix Inc. (NASDAQ:CRMD) gained 10.4% to close at $3.61. CorMedix recently reported better-than-expected Q1 EPS results.
    • Verb Technology Company, Inc. (NASDAQ:VERB) gained 10% to close at $0.3279.
    • Fast Radius, Inc. (NASDAQ:FSRD) rose 7.2% to settle at $0.6249. Needham maintained Fast Radius with a Buy and lowered the price target from $4 to $3.


    Losers

    • Chimerix, Inc. (NASDAQ:CMRX) shares tumbled 60.9% to close at $1.66 on Monday. Emergent BioSolutions Inc (NYSE:EBS) agreed to acquire Chimerix’s exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.
    • Predictive Oncology Inc. (NASDAQ:POAI) declined 45.8% to settle at $0.3787 after the company announced $7.2 million registered direct offerings.
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 37.7% to close at $17.49. After the closing bell, Forge Global reported first-quarter revenue of $20.02 million, which was down from revenue of $32.06 million in the prior year quarter.
    • Iris Energy Limited (NASDAQ:IREN) shares dropped 36.5% to close at $4.90 after jumping around 17% on Friday. The company recently posted downbeat quarterly sales.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) fell 31.4% to settle at $0.0904. Tonix Pharmaceuticals reported a 1-for-32 reverse stock split.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) dipped 27.6% to close at $4.10. Blue Water Vaccines reported a Q1 loss of $0.34 per share.
    • Pintec Technology Holdings Limited (NASDAQ:PT) fell 26.5% to close at $1.71.
    • FedNat Holding Company (NASDAQ:FNHC) dipped 25.1% to close at $0.3415. FedNat recently reported worse-than-expected Q1 adjusted EPS and sales results.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) fell 23.4% to close at $3.37 after the company reported a Q1 loss of $0.50 per share.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 23.1% to $0.3921 after jumping 155% on Friday.
    • Lucira Health, Inc. (NASDAQ:LHDX) dropped 22.9% to close at $2.05. Lucira Health recently posted Q1 adjusted net income of $16.668 million.
    • Aeterna Zentaris Inc. (NASDAQ:AEZS) fell 22.7% to settle at $0.1895.
    • SQL Technologies Corp. (NASDAQ:SKYX) dipped 22.2% to close at $4.21.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 21.9% to close at $7.44.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) declined 20.7% to close at $0.5552.
    • Valneva SE (NASDAQ:VALN) fell 20.6% to settle at $19.80. Valneva warned it might have to reconsider its FY22 financial guidance after the European Commission informed the company of its intent to terminate an advance purchase agreement (APA) for its VLA2001 COVID-19 candidate vaccine.
    • PolarityTE, Inc. (NASDAQ:PTE) fell 19.4% to close at $0.1706 after jumping around 45% on Friday. The U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s SkinTE under the its open investigational new drug application (IND).
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) declined 19.1% to settle at $0.9628. Aprea Therapeutics posted a Q1 loss of $0.36 per share.
    • Inhibrx, Inc. (NASDAQ:INBX) declined 19% to close at $13.73. Inhibrx announced topline results from a Phase 1 clinical trial of INBRX-101, an optimized recombinant human AAT-Fc fusion protein, in patients with alpha-1 antitrypsin deficiency (AATD).
    • Actelis Networks, Inc. (NASDAQ:ASNS) fell 18.8% to close at $1.95. The company recently priced its IPO at $4 per share.
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) dipped 18.7% to settle at $1.70. The company recently posted upbeat quarterly sales.
    • Datasea Inc. (NASDAQ:DTSS) declined 17.9% to settle at $1.84 after the company reported Q3 earnings results.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) dropped 17.7% to close at $10.59.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) fell 15.8% to settle at $2.03.
    • Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares fell 15.4% to close at $0.38 after gaining around 9% on Friday. Akebia Therapeutics posted a Q1 loss of $0.35 per share.
    • Humacyte, Inc. (NASDAQ:HUMA) fell 15.1% to close at $4.56. Humacyte posted a Q1 loss of $0.19 per share.
    • Cyngn Inc. (NASDAQ:CYN) fell 14.9% to close at $2.80.
    • Arcellx, Inc. (NASDAQ:ACLX) declined 14.6% to settle at $7.61. Arcellx recently posted a Q1 loss of $1.56 per share.
    • InnovAge Holding Corp. (NASDAQ:INNV) dipped 11.7% to close at $4.53. Baird downgraded InnovAge Holding from Outperform to Neutral and lowered the price target from $6 to $5.
    • Nu Holdings Ltd. (NYSE:NU) fell 9.8% to close at $4.35.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) fell 9.3% to close at $3.22 after jumping 15% on Friday.
    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $ADMP
    $AEZS
    $AGRI

    CompanyDatePrice TargetRatingAnalyst
    Clear Secure Inc.
    $YOU
    2/26/2026$45.00 → $55.00Outperform
    Telsey Advisory Group
    Teekay Tankers Ltd.
    $TNK
    2/20/2026Buy → Hold
    DNB Markets
    Arcellx Inc.
    $ACLX
    2/12/2026$82.00Buy → Neutral
    Rothschild & Co Redburn
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    IREN Limited
    $IREN
    1/13/2026$80.00Sell → Buy
    H.C. Wainwright
    Arcellx Inc.
    $ACLX
    1/7/2026$100.00Buy
    UBS
    Oric Pharmaceuticals Inc.
    $ORIC
    1/7/2026$22.00Overweight
    Piper Sandler
    Arcellx Inc.
    $ACLX
    12/22/2025$100.00Overweight
    Wells Fargo
    More analyst ratings

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    SEC Filings

    View All

    SEC Form 144 filed by Arcellx Inc.

    144 - Arcellx, Inc. (0001786205) (Subject)

    2/27/26 7:31:42 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Clear Secure Inc.

    144 - Clear Secure, Inc. (0001856314) (Subject)

    2/27/26 4:04:52 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Clear Secure with a new price target

    Telsey Advisory Group reiterated coverage of Clear Secure with a rating of Outperform and set a new price target of $55.00 from $45.00 previously

    2/26/26 6:51:04 AM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    Teekay Tankers downgraded by DNB Markets

    DNB Markets downgraded Teekay Tankers from Buy to Hold

    2/20/26 8:23:03 AM ET
    $TNK
    Marine Transportation
    Consumer Discretionary

    Arcellx downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Arcellx from Buy to Neutral and set a new price target of $82.00

    2/12/26 7:20:24 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tidewater Announces Earnings Release and Conference Call

    Tidewater Inc. (NYSE:TDW) ("Tidewater" or the "Company") announced today that it will release financial results for the three and twelve months ending December 31, 2025, on Monday, March 2, 2026, after market close. An earnings conference call has been scheduled for Tuesday, March 3, 2026, at 8:00 a.m. Central Time, during which President and Chief Executive Officer Quintin Kneen will discuss results for the three and twelve months ending December 31, 2025. Investors and interested parties may listen to the earnings conference call via telephone by calling +1.800.715.9871 if calling from the U.S. or Canada (+1.647.932.3411 if calling from outside the U.S.) and provide Conference ID: 87456

    2/26/26 10:09:00 PM ET
    $TDW
    Marine Transportation
    Consumer Discretionary

    Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit

    Four Orange Book Listed Patents through March 2040 Orphan Drug Exclusivity through December 2028 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, announced that its subsidiaries, Xeris Pharmaceuticals, Inc. and Strongbridge Dublin Limited, have filed a patent infringement lawsuit under the Hatch-Waxman Act related to Recorlev® (levoketoconazole) in the United States District Court for the District of New Jersey against Torrent Pharmaceuticals Limited (along with its affiliate) and Somerset Therapeutics, LLC (along with its affiliat

    2/26/26 5:55:00 PM ET
    $XERS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Elghandour Rami converted options into 164,548 shares and sold $10,243,267 worth of shares (89,916 units at $113.92), decreasing direct ownership by 55% to 276,051 units (SEC Form 4)

    4 - Arcellx, Inc. (0001786205) (Issuer)

    2/27/26 7:48:11 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Wiener Adam sold $1,525,280 worth of shares (33,000 units at $46.22), decreasing direct ownership by 20% to 132,634 units (SEC Form 4)

    4 - Clear Secure, Inc. (0001856314) (Issuer)

    2/27/26 7:47:03 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    GC & Chief Privacy Officer Haaland Lynn sold $698,986 worth of shares (15,533 units at $45.00), closing all direct ownership in the company (SEC Form 4)

    4 - Clear Secure, Inc. (0001856314) (Issuer)

    2/27/26 7:45:33 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 17, 2023 - FDA Roundup: November 17, 2023

    For Immediate Release: November 17, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, to mark the 15th anniversary of the FDA foreign offices, the FDA published an interview with Susan Winckler, who was FDA chief of staff when the first office was opened in Beijing on November 19, 2008. Winckler is now CEO of the Reagan-Udall Foundation

    11/17/23 4:18:44 PM ET
    $BMY
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DEFENCATH issued to CORMEDIX INC

    Submission status for CORMEDIX INC's drug DEFENCATH (ORIG-1) with active ingredient TAUROLIDINE AND HEPARIN SODIUM has changed to 'Approval' on 11/15/2023. Application Category: NDA, Application Number: 214520, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    11/15/23 9:53:06 AM ET
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carver Bancorp Inc.

    SC 13D/A - CARVER BANCORP INC (0001016178) (Subject)

    12/12/24 5:00:53 PM ET
    $CARV
    Savings Institutions
    Finance

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    TV ONE NETWORKS APPOINTS KEITH HOPKINS AS VICE PRESIDENT, CONTENT DISTRIBUTION & MARKETING

    SILVER SPRING, MD., Feb. 24, 2026 (GLOBE NEWSWIRE) -- TV One Networks today announced the appointment of Keith Hopkins as the new Vice President of Content Distribution & Marketing. Hopkins brings two decades of experience spanning content distribution, sports partnerships, and streaming strategy, having held senior leadership roles at Roku, Nexstar Media Group, Pac-12 Conference and NBCUniversal/Comcast. In his new role, Hopkins will lead the company's distribution and partnership marketing strategy across all linear and digital platforms, domestically and internationally, maximizing reach and revenue opportunities for TV One and CLEO TV.  Most recently at Roku, Hopkins hel

    2/24/26 9:15:17 AM ET
    $UONE
    Broadcasting
    Consumer Discretionary

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    $ACLX
    $ADMP
    $AEZS
    $AGRI
    Financials

    Live finance-specific insights

    View All

    Tidewater Announces Earnings Release and Conference Call

    Tidewater Inc. (NYSE:TDW) ("Tidewater" or the "Company") announced today that it will release financial results for the three and twelve months ending December 31, 2025, on Monday, March 2, 2026, after market close. An earnings conference call has been scheduled for Tuesday, March 3, 2026, at 8:00 a.m. Central Time, during which President and Chief Executive Officer Quintin Kneen will discuss results for the three and twelve months ending December 31, 2025. Investors and interested parties may listen to the earnings conference call via telephone by calling +1.800.715.9871 if calling from the U.S. or Canada (+1.647.932.3411 if calling from outside the U.S.) and provide Conference ID: 87456

    2/26/26 10:09:00 PM ET
    $TDW
    Marine Transportation
    Consumer Discretionary

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Teknova Reports Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany provides 2026 revenue guidance of $42-44 million HOLLISTER, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova" or the "Company") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and full year ended December 31, 2025. "After another successful year of disciplined execution against our strategic objectives,

    2/26/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care